Elisabeth Baugh, Ovarian Cancer Champion, to Retire
CCRA members congratulate Elisabeth Baugh on her pending retirement as CEO of Ovarian Cancer Canada. Elisabeth has been at the helm of the organization since its founding. Under Elisabeth’s leadership, Ovarian Cancer Canada has grown its national presence and her commitment to women living with ovarian cancer and passion for advancing game-changing research helped secure federal and partnered funding for OvCAN. This initiative is focused on finding the best research models for ovarian cancer, identifying the most promising novel treatments, and advancing clinical trials using a personalized medicine approach.
Beyond Canada, Elisabeth chaired the first ever World Ovarian Cancer Day in 2013 and has served as chair of the World Ovarian Cancer Coalition since its inception, working to increase the international profile of this important cause.
We wish Elisabeth the very best in upcoming retirement. She will be missed at the CCRA table.
Spanning Bench to Behaviour: Webinar
This webinar, "Spanning Bench to Behaviour: Harnessing CPTP data to understand lifestyle risks across the health spectrum," will provide an overview of the types of data collected through the Canadian Partnership for Tomorrow Project (CPTP) — Canada’s largest population study of 330,000 Canadians in six regional cohorts across the... Read More »
This webinar, "Spanning Bench to Behaviour: Harnessing CPTP data to understand lifestyle risks across the health spectrum," will provide an overview of the types of data collected through the Canadian Partnership for Tomorrow Project (CPTP) — Canada’s largest population study of 330,000 Canadians in six regional cohorts across the... Read More »
2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-related health services ... Read More »
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year's report includes some new analyses, which quantify the cancer-related health services ... Read More »